ID

15591

Descrizione

Selenium in Preventing Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00978718

collegamento

https://clinicaltrials.gov/show/NCT00978718

Keywords

versioni (1)
  1. 04/06/16 04/06/16 -
Caricato su

4 giugno 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Prostate Cancer NCT00978718

Inglese

Eligibility Prostate Cancer NCT00978718

1 moduli  
Criteria
Descrizione

Criteria

clinical indicators consistent with the community standards of medical care that would justify a biopsy of the prostate for the diagnosis of cancer, including ≥ 1 of the following:
Descrizione

prostate cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0600139
psa level above the absolute value of 4 ng/ml or above a published age-ethnic adjusted psa level appropriate for the community
Descrizione

elevated PSA level

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0138741
UMLS CUI [1,2]
C3163633
rising psa that should represent a clinically significant psa velocity (e.g., an estimated annual change in the psa velocity ≥ 0.75 ng/ml)
Descrizione

significant psa velocity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1518823
abnormal digital rectal examination of the prostate that identifies a clinically significant change in the prostate (e.g., a prostate nodule or a change in the firmness of the prostate)
Descrizione

clinically significant change in the prostate

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1096657
documentation of the clinical assessment that justified the prostate biopsy that allows classification of the patient to high-risk groups
Descrizione

prostate biopsy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0194804
prostate biopsy negative for cancer within the past 12 months
Descrizione

prostate biopsy negative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0194804
UMLS CUI [1,2]
C0205160
prostate biopsy negative for high-grade prostatic intraepithelial neoplasia (pin)
Descrizione

negative for high-grade prostatic intraepithelial neoplasia

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0194804
UMLS CUI [1,2]
C0205160
UMLS CUI [1,3]
C1168327
pin allowed provided it is grade 1
Descrizione

PIN grade 1

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0282612
UMLS CUI [1,2]
C0687695
creatinine < 2 times upper limit of normal (uln)
Descrizione

creatinine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0010294
bilirubin < 2 times uln
Descrizione

bilirubin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005437
sgot and sgpt < 2 times uln
Descrizione

sgot and sgpt

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
alkaline phosphatase < 2 times uln
Descrizione

alkaline phosphatase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201850
no history of a prior malignancy except for the following:
Descrizione

history of malignancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
adequately treated basal cell or squamous cell carcinoma
Descrizione

basal cell or squamous cell carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0007137
UMLS CUI [2,2]
C0087111
adequately treated (i.e., complete surgical removal with negative margins) stage i cancer from which the patient is currently in complete remission
Descrizione

complete remission

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0677874
UMLS CUI [1,2]
C0087111
any other cancer from which the patient has been disease-free for 5 years
Descrizione

other cancer

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1707251
UMLS CUI [1,2]
C0242793
no prior systemic chemotherapy or radiotherapy
Descrizione

chemotherapy or radiotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
at least 90 days since prior and no other concurrent selenium > 55 μg/day as a dietary supplement (including multivitamin supplements)
Descrizione

concurrent selenium

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0521939
more than 30 days since prior and no concurrent participation in any other clinical trial involving a medical, surgical, nutritional, or life-style intervention (e.g., dietary modifications, exercise)
Descrizione

concurrent participation in any other clinical trial

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
Ritorna all'inizio della pagina

Similar models

Eligibility Prostate Cancer NCT00978718

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
prostate cancer
Item
clinical indicators consistent with the community standards of medical care that would justify a biopsy of the prostate for the diagnosis of cancer, including ≥ 1 of the following:
boolean
C0600139 (UMLS CUI [1])
elevated PSA level
Item
psa level above the absolute value of 4 ng/ml or above a published age-ethnic adjusted psa level appropriate for the community
boolean
C0138741 (UMLS CUI [1,1])
C3163633 (UMLS CUI [1,2])
significant psa velocity
Item
rising psa that should represent a clinically significant psa velocity (e.g., an estimated annual change in the psa velocity ≥ 0.75 ng/ml)
boolean
C1518823 (UMLS CUI [1])
clinically significant change in the prostate
Item
abnormal digital rectal examination of the prostate that identifies a clinically significant change in the prostate (e.g., a prostate nodule or a change in the firmness of the prostate)
boolean
C1096657 (UMLS CUI [1])
prostate biopsy
Item
documentation of the clinical assessment that justified the prostate biopsy that allows classification of the patient to high-risk groups
boolean
C0194804 (UMLS CUI [1])
prostate biopsy negative
Item
prostate biopsy negative for cancer within the past 12 months
boolean
C0194804 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
negative for high-grade prostatic intraepithelial neoplasia
Item
prostate biopsy negative for high-grade prostatic intraepithelial neoplasia (pin)
boolean
C0194804 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
C1168327 (UMLS CUI [1,3])
PIN grade 1
Item
pin allowed provided it is grade 1
boolean
C0282612 (UMLS CUI [1,1])
C0687695 (UMLS CUI [1,2])
creatinine
Item
creatinine < 2 times upper limit of normal (uln)
boolean
C0010294 (UMLS CUI [1])
bilirubin
Item
bilirubin < 2 times uln
boolean
C0005437 (UMLS CUI [1])
sgot and sgpt
Item
sgot and sgpt < 2 times uln
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
alkaline phosphatase
Item
alkaline phosphatase < 2 times uln
boolean
C0201850 (UMLS CUI [1])
history of malignancy
Item
no history of a prior malignancy except for the following:
boolean
C0006826 (UMLS CUI [1])
basal cell or squamous cell carcinoma
Item
adequately treated basal cell or squamous cell carcinoma
boolean
C0007117 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0007137 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
complete remission
Item
adequately treated (i.e., complete surgical removal with negative margins) stage i cancer from which the patient is currently in complete remission
boolean
C0677874 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
other cancer
Item
any other cancer from which the patient has been disease-free for 5 years
boolean
C1707251 (UMLS CUI [1,1])
C0242793 (UMLS CUI [1,2])
chemotherapy or radiotherapy
Item
no prior systemic chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
concurrent selenium
Item
at least 90 days since prior and no other concurrent selenium > 55 μg/day as a dietary supplement (including multivitamin supplements)
boolean
C0521939 (UMLS CUI [1])
concurrent participation in any other clinical trial
Item
more than 30 days since prior and no concurrent participation in any other clinical trial involving a medical, surgical, nutritional, or life-style intervention (e.g., dietary modifications, exercise)
boolean
C2348568 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial